RSH 13.0% 2.6¢ respiri limited

Ann: Investor webinar and Q&A to be held Feb 23rd, page-3

  1. 26,683 Posts.
    lightbulb Created with Sketch. 1731
    I'm not an investor but you already know my opinion from my due diligence, wheezing doesn't mean you are having an Asthma attack or even Asthma, that's why RSH are doing further clinical studies on how wheezing affect lung function and waiting for medical board approval to start.

    Hence why I said the product has a small niche market, why do you think RSH did a failed T/O of ADR's IP which has a MC of only $30M and now RSH are developing Sorfe which supposedly will "complement" wheezo somehow.
 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
(20min delay)
Last
2.6¢
Change
0.003(13.0%)
Mkt cap ! $29.81M
Open High Low Value Volume
2.2¢ 2.6¢ 2.1¢ $17.69K 789.3K

Buyers (Bids)

No. Vol. Price($)
2 99463 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 199999 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RSH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.